Acetaminophen, Asprin, Caffeine

CHEBI:CHEBI_749436

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

active_ingredient_name
ASPIRIN
rxcui
209468
pharm_class
Decreased Platelet Aggregation [PE]
marketing_category
OTC MONOGRAPH DRUG
listing_expiration_date
20251231
route
ORAL
unii
R16CO5Y76E
active_ingredient_strength
65 mg/1
nui
N0000008832
pharm_class_epc
Platelet Aggregation Inhibitor [EPC]
pharm_class_moa
Cyclooxygenase Inhibitors [MoA]
pharm_class_cs
Xanthines [CS]
pharm_class_pe
Decreased Platelet Aggregation [PE]
product_type
HUMAN OTC DRUG
dosage_form
TABLET, COATED
application_number
NDA020802
labeler_name
Haleon US Holdings LLC
manufacturer_name
Haleon US Holdings LLC
brand_name_base
Excedrin
generic_name
Acetaminophen, Asprin, Caffeine
brand_name
Excedrin Extra Strength Geltabs
brand_name_suffix
Extra Strength Geltabs
product_ndc
0067-2021
marketing_start_date
20110913
package_marketing_start_date
20110913
spl_id
09d7d5f9-c9f1-4942-8dc8-13ca8e164ce9
package_ndc
0067-2021-80
package_description
1 BOTTLE in 1 CARTON (0067-2021-80) / 80 TABLET, COATED in 1 BOTTLE
spl_set_id
11a8439b-0159-4351-b0f5-fe7fad6a33c0
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class